Last reviewed · How we verify
NCT06953349
Efficacy of Surgical Systems in Combination With Phacoemulsification: a Retrospective Analysis
trial testing Real-World efficacy of Hydrus Microstent with OMNI Surgical System in combination with Phacoemulsification: a retrospective analysis in Open-Angle Glaucoma in 300 participants. Currently enrolling.
30 November 2025
Quick facts
| Lead sponsor | Barnet Dulaney Perkins Eye Centers |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 300 |
| Start date | 31 March 2025 |
| Primary completion | 30 November 2025 |
| Estimated completion | 31 December 2025 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Real-World efficacy of Hydrus Microstent with OMNI Surgical System in combination with Phacoemulsification: a retrospective analysis
Conditions studied
- Open-Angle Glaucoma — all drugs for Open-Angle Glaucoma →
Sponsor
Barnet Dulaney Perkins Eye Centers
Who can join
18 and older, any sex, with Open-Angle Glaucoma. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Real-World efficacy of Hydrus Microstent with OMNI Surgical System in combination with Phacoemulsification: a retrospective analysis
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06953349
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Open-Angle Glaucoma
Currently open trials in the same condition.
- NCT07217678 — Biomarkers of Ocular Surface Damage in the Setting of Topical Ocular Hypotensive Medication Use · Phase 4 · recruiting
- NCT07081347 — This Follow-up Extension Study is Aimed to Monitor the Long-term IOP-lowering Performance/Efficacy and Safety of the MIN · NA · active not recruiting
Other Barnet Dulaney Perkins Eye Centers trials
Trials by the same sponsor.
- NCT06933836 — DSLT Performance in Treatment-naïve Patients With Newly Diagnosed Open Angle Glaucoma · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06953349 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Barnet Dulaney Perkins Eye Centers
- Last refreshed: 1 May 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06953349.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing